Cargando…

Nimbolide, a neem limonoid inhibits cytoprotective autophagy to activate apoptosis via modulation of the PI3K/Akt/GSK-3β signalling pathway in oral cancer

Of late, nimbolide, a limonoid from the neem tree (Azadirachta indica) has gained increasing research attention owing to its potent antiproliferative and apoptosis-inducing effects. The present study was designed to investigate the effect of nimbolide on autophagy and the time point at which the pho...

Descripción completa

Detalles Bibliográficos
Autores principales: Sophia, Josephraj, Kowshik, Jaganathan, Dwivedi, Anju, Bhutia, Sujit K, Manavathi, Bramanandam, Mishra, Rajakishore, Nagini, Siddavaram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199248/
https://www.ncbi.nlm.nih.gov/pubmed/30352996
http://dx.doi.org/10.1038/s41419-018-1126-4
_version_ 1783365102815150080
author Sophia, Josephraj
Kowshik, Jaganathan
Dwivedi, Anju
Bhutia, Sujit K
Manavathi, Bramanandam
Mishra, Rajakishore
Nagini, Siddavaram
author_facet Sophia, Josephraj
Kowshik, Jaganathan
Dwivedi, Anju
Bhutia, Sujit K
Manavathi, Bramanandam
Mishra, Rajakishore
Nagini, Siddavaram
author_sort Sophia, Josephraj
collection PubMed
description Of late, nimbolide, a limonoid from the neem tree (Azadirachta indica) has gained increasing research attention owing to its potent antiproliferative and apoptosis-inducing effects. The present study was designed to investigate the effect of nimbolide on autophagy and the time point at which the phosphorylation status of GSK-3β and PI3K dictate the choice between autophagy and apoptosis in SCC131 and SCC4 oral cancer cells. Additionally, we analysed changes in the expression of proteins involved in autophagy and apoptosis after therapeutic intervention with nimbolide in a hamster model of oral oncogenesis. Furthermore, we also demonstrate changes in the expression of key genes involved in apoptosis and autophagy during the stepwise evolution of hamster and human OSCCs. Nimbolide-induced stereotypical changes in oral cancer cells characteristic of both apoptosis and autophagy. Time-course experiments revealed that nimbolide induces autophagy as an early event and then switches over to apoptosis. Nimbolide negatively regulates PI3K/Akt signalling with consequent increase in p-GSK-3β(Tyr216), the active form of GSK-3β that inhibits autophagy. Downregulation of HOTAIR, a competing endogenous RNA that sponges miR-126 may be a major contributor to the inactivation of PI3K/Akt/GSK3 signalling by nimbolide. Analysis of key markers of apoptosis and autophagy as well as p-Akt(Ser473) during sequential progression of hamster and human OSCC revealed a gradual evolution to a pro-autophagic and antiapoptotic phenotype that could confer a survival advantage to tumors. In summary, the results of the present study provide insights into the molecular mechanisms by which nimbolide augments apoptosis by overcoming the shielding effects of cytoprotective autophagy through modulation of the phosphorylation status of Akt and GSK-3β as well as the ncRNAs miR-126 and HOTAIR. Development of phytochemicals such as nimbolide that target the complex interaction between proteins and ncRNAs that regulate the autophagy/apoptosis flux is of paramount importance in cancer prevention and therapeutics.
format Online
Article
Text
id pubmed-6199248
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-61992482018-10-24 Nimbolide, a neem limonoid inhibits cytoprotective autophagy to activate apoptosis via modulation of the PI3K/Akt/GSK-3β signalling pathway in oral cancer Sophia, Josephraj Kowshik, Jaganathan Dwivedi, Anju Bhutia, Sujit K Manavathi, Bramanandam Mishra, Rajakishore Nagini, Siddavaram Cell Death Dis Article Of late, nimbolide, a limonoid from the neem tree (Azadirachta indica) has gained increasing research attention owing to its potent antiproliferative and apoptosis-inducing effects. The present study was designed to investigate the effect of nimbolide on autophagy and the time point at which the phosphorylation status of GSK-3β and PI3K dictate the choice between autophagy and apoptosis in SCC131 and SCC4 oral cancer cells. Additionally, we analysed changes in the expression of proteins involved in autophagy and apoptosis after therapeutic intervention with nimbolide in a hamster model of oral oncogenesis. Furthermore, we also demonstrate changes in the expression of key genes involved in apoptosis and autophagy during the stepwise evolution of hamster and human OSCCs. Nimbolide-induced stereotypical changes in oral cancer cells characteristic of both apoptosis and autophagy. Time-course experiments revealed that nimbolide induces autophagy as an early event and then switches over to apoptosis. Nimbolide negatively regulates PI3K/Akt signalling with consequent increase in p-GSK-3β(Tyr216), the active form of GSK-3β that inhibits autophagy. Downregulation of HOTAIR, a competing endogenous RNA that sponges miR-126 may be a major contributor to the inactivation of PI3K/Akt/GSK3 signalling by nimbolide. Analysis of key markers of apoptosis and autophagy as well as p-Akt(Ser473) during sequential progression of hamster and human OSCC revealed a gradual evolution to a pro-autophagic and antiapoptotic phenotype that could confer a survival advantage to tumors. In summary, the results of the present study provide insights into the molecular mechanisms by which nimbolide augments apoptosis by overcoming the shielding effects of cytoprotective autophagy through modulation of the phosphorylation status of Akt and GSK-3β as well as the ncRNAs miR-126 and HOTAIR. Development of phytochemicals such as nimbolide that target the complex interaction between proteins and ncRNAs that regulate the autophagy/apoptosis flux is of paramount importance in cancer prevention and therapeutics. Nature Publishing Group UK 2018-10-23 /pmc/articles/PMC6199248/ /pubmed/30352996 http://dx.doi.org/10.1038/s41419-018-1126-4 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Sophia, Josephraj
Kowshik, Jaganathan
Dwivedi, Anju
Bhutia, Sujit K
Manavathi, Bramanandam
Mishra, Rajakishore
Nagini, Siddavaram
Nimbolide, a neem limonoid inhibits cytoprotective autophagy to activate apoptosis via modulation of the PI3K/Akt/GSK-3β signalling pathway in oral cancer
title Nimbolide, a neem limonoid inhibits cytoprotective autophagy to activate apoptosis via modulation of the PI3K/Akt/GSK-3β signalling pathway in oral cancer
title_full Nimbolide, a neem limonoid inhibits cytoprotective autophagy to activate apoptosis via modulation of the PI3K/Akt/GSK-3β signalling pathway in oral cancer
title_fullStr Nimbolide, a neem limonoid inhibits cytoprotective autophagy to activate apoptosis via modulation of the PI3K/Akt/GSK-3β signalling pathway in oral cancer
title_full_unstemmed Nimbolide, a neem limonoid inhibits cytoprotective autophagy to activate apoptosis via modulation of the PI3K/Akt/GSK-3β signalling pathway in oral cancer
title_short Nimbolide, a neem limonoid inhibits cytoprotective autophagy to activate apoptosis via modulation of the PI3K/Akt/GSK-3β signalling pathway in oral cancer
title_sort nimbolide, a neem limonoid inhibits cytoprotective autophagy to activate apoptosis via modulation of the pi3k/akt/gsk-3β signalling pathway in oral cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199248/
https://www.ncbi.nlm.nih.gov/pubmed/30352996
http://dx.doi.org/10.1038/s41419-018-1126-4
work_keys_str_mv AT sophiajosephraj nimbolideaneemlimonoidinhibitscytoprotectiveautophagytoactivateapoptosisviamodulationofthepi3kaktgsk3bsignallingpathwayinoralcancer
AT kowshikjaganathan nimbolideaneemlimonoidinhibitscytoprotectiveautophagytoactivateapoptosisviamodulationofthepi3kaktgsk3bsignallingpathwayinoralcancer
AT dwivedianju nimbolideaneemlimonoidinhibitscytoprotectiveautophagytoactivateapoptosisviamodulationofthepi3kaktgsk3bsignallingpathwayinoralcancer
AT bhutiasujitk nimbolideaneemlimonoidinhibitscytoprotectiveautophagytoactivateapoptosisviamodulationofthepi3kaktgsk3bsignallingpathwayinoralcancer
AT manavathibramanandam nimbolideaneemlimonoidinhibitscytoprotectiveautophagytoactivateapoptosisviamodulationofthepi3kaktgsk3bsignallingpathwayinoralcancer
AT mishrarajakishore nimbolideaneemlimonoidinhibitscytoprotectiveautophagytoactivateapoptosisviamodulationofthepi3kaktgsk3bsignallingpathwayinoralcancer
AT naginisiddavaram nimbolideaneemlimonoidinhibitscytoprotectiveautophagytoactivateapoptosisviamodulationofthepi3kaktgsk3bsignallingpathwayinoralcancer